ECSP034558A - STROGEN RECEIVER MODULATORS - Google Patents

STROGEN RECEIVER MODULATORS

Info

Publication number
ECSP034558A
ECSP034558A EC2003004558A ECSP034558A ECSP034558A EC SP034558 A ECSP034558 A EC SP034558A EC 2003004558 A EC2003004558 A EC 2003004558A EC SP034558 A ECSP034558 A EC SP034558A EC SP034558 A ECSP034558 A EC SP034558A
Authority
EC
Ecuador
Prior art keywords
strogen
receiver modulators
modulators
receiver
graph
Prior art date
Application number
EC2003004558A
Other languages
Spanish (es)
Inventor
Frank P Dininno
Jane Y Wu
Seongkon Kim
Helen Y Chen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ECSP034558A publication Critical patent/ECSP034558A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula que consta en el gráfico y que se describe en la reivindicación 1 del invento (gráfico).A compound of the formula that appears in the graph and is described in claim 1 of the invention (graph).

EC2003004558A 2000-10-19 2003-04-17 STROGEN RECEIVER MODULATORS ECSP034558A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24158200P 2000-10-19 2000-10-19

Publications (1)

Publication Number Publication Date
ECSP034558A true ECSP034558A (en) 2003-06-25

Family

ID=22911282

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004558A ECSP034558A (en) 2000-10-19 2003-04-17 STROGEN RECEIVER MODULATORS

Country Status (20)

Country Link
EP (1) EP1333827A2 (en)
JP (1) JP2004511502A (en)
KR (1) KR20030042020A (en)
CN (1) CN1469743A (en)
AU (2) AU2002232381B2 (en)
BG (1) BG107676A (en)
BR (1) BR0114689A (en)
CA (1) CA2424729A1 (en)
EA (1) EA200300474A1 (en)
EC (1) ECSP034558A (en)
EE (1) EE200300153A (en)
HU (1) HUP0303563A2 (en)
IL (1) IL154984A0 (en)
IS (1) IS6761A (en)
MX (1) MXPA03003485A (en)
NO (1) NO20031737L (en)
PE (1) PE20021083A1 (en)
PL (1) PL361053A1 (en)
SK (1) SK4772003A3 (en)
WO (1) WO2002032377A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225132A1 (en) * 2002-04-11 2003-12-04 Dininno Frank P. Estrogen receptor modulators
JP4554219B2 (en) 2002-04-24 2010-09-29 メルク・シャープ・エンド・ドーム・コーポレイション Estrogen receptor modulator
CN1939314A (en) 2002-05-10 2007-04-04 弗·哈夫曼-拉罗切有限公司 Ibandronic acid for the treatment and prevention of osteoporosis
WO2004058682A1 (en) * 2002-12-26 2004-07-15 Eisai Co., Ltd. Selective estrogen receptor modulators
US8410109B2 (en) 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
EP1944301A4 (en) * 2005-10-27 2012-01-04 Msd Kk NEW BENZOXATHINE DERIVATIVE
MX2009008099A (en) 2007-02-01 2009-12-14 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases.
CA2747417C (en) 2009-01-08 2017-01-03 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101913109B1 (en) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 Novel anti-inflammatory agents
DK2421533T3 (en) 2009-04-22 2019-01-07 Resverlogix Corp Hitherto unknown anti-inflammatory agents
BR112012031464A2 (en) 2010-06-10 2020-08-04 Aragon Pharmaceuticals, Inc. estrogen receptor modulators and their uses
US8853423B2 (en) 2010-06-17 2014-10-07 Seragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
LT2773354T (en) 2011-11-01 2019-08-12 Resverlogix Corp. Oral immediate release formulations for substituted quinazolinones
SG11201403002RA (en) 2011-12-14 2014-07-30 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014096965A2 (en) 2012-12-21 2014-06-26 Rvx Therapeutics Inc. Novel heterocyclic compounds as bromodomain inhibitors
JP6903585B2 (en) 2015-03-13 2021-07-14 レスバーロジックス コーポレイション Compositions and Therapeutic Methods for the Treatment of Complement-Related Diseases

Also Published As

Publication number Publication date
NO20031737D0 (en) 2003-04-15
AU2002232381B2 (en) 2004-11-18
BR0114689A (en) 2003-07-01
MXPA03003485A (en) 2003-07-14
AU3238102A (en) 2002-04-29
HUP0303563A2 (en) 2004-03-01
NO20031737L (en) 2003-06-19
EP1333827A2 (en) 2003-08-13
SK4772003A3 (en) 2003-08-05
CN1469743A (en) 2004-01-21
IS6761A (en) 2003-03-27
BG107676A (en) 2003-11-28
WO2002032377A3 (en) 2002-08-22
PE20021083A1 (en) 2002-12-16
JP2004511502A (en) 2004-04-15
PL361053A1 (en) 2004-09-20
IL154984A0 (en) 2003-10-31
EE200300153A (en) 2003-06-16
WO2002032377A2 (en) 2002-04-25
CA2424729A1 (en) 2002-04-25
EA200300474A1 (en) 2003-10-30
KR20030042020A (en) 2003-05-27

Similar Documents

Publication Publication Date Title
ECSP034558A (en) STROGEN RECEIVER MODULATORS
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
DOP2001000151A (en) IMIDAZOPIRIMIDINE DERIVATIVES AND TRIAZOLOPIMIDINE DERIVATIVES.
DE69925133D1 (en) PYRROLOBENZODIAZEPINE
TR200202194T2 (en) Polyglutamic acid-camptothecin compounds and preparation methods
AR015379A1 (en) ASCORBIL-FOSFORIL-CHOLESTEROL
ECSP045245A (en) N-ARIL-2-OXAZOLIDINONA-5-CARBOXAMIDS AND ITS DERIVATIVES
DE60135919D1 (en) FARNESYL TRANSFERASE-INHIBITING 6-HETEROCYCLYLMETHYL-CHINOLINE AND CHINAZOLE DERIVATIVES
PA8522701A1 (en) COMPOUNDS OF BENCENIC ACETAMIDS THAT ARE ACTIVATORS OF GLUCOKINASE a-ACILO-Y a-HETEROATOMO-REPLACED
JO2410B1 (en) Substituted 6-pyrido-pyrimidines
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
HN2002000235A (en) FORMULATIONS IN COMBINATION OF DERIVATIVES OF 1, 4 - BENZOTHYPINE - 1, 1 - DIOXIDE WITH OTHER ACTIVE SUBSTANCES, AND THEIR USE
PA8553101A1 (en) FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND ITS USE
HN2001000277A (en) PIRROLO [2,1 - a] DIHYDROISOQUINOLINS
ES2189657B1 (en) PESTICIDE RESIN COMPOSITIONS.
PA8543701A1 (en) PHENYL-HETEROCICLIL-ETERES
MY128164A (en) Compounds
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
BR0114065A (en) Triazole-epothilones
GT199900037A (en) NEW HERBICIDE COMPOSITIONS.
BR0313400A (en) N-aryl-2-oxazolidinones and their derivatives
ATE401325T1 (en) C10-CARBAMOYLOXY SUBSTITUTED TAXANES AS ANTI-TUMOR AGENTS
DK1165549T3 (en) C7 carbamoyloxy-substituted taxanes as antitumor agents
DOP2000000050A (en) ANTI-COLOR COMPOSITION
BR0113202A (en) Trioxepane compounds